Skip to main content
SYRE filings

Corporate insider profile

Sheldon Sloan Filing Activity

Latest reported as Chief Medical Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$6,225,674.83
Latest transaction
Jun 3, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 3, 2026Spyre Therapeutics, Inc. (SYRE)Chief Medical OfficerSale8,333$75.00$624,975
May 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Medical OfficerSale78,333$71.50$5,600,700